Learn more about our work for Small Businesses.
Following the introduction of the bipartisan American Innovation and Jobs Act in the U.S. Senate and its House companion the American Innovation and R&D Competitiveness Act, AdvaMed®, the MedTech Association,…
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed®…
AdvaMed Accel® held the 3rd Quarter meeting of the Medtech Investment Working Group.
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed®’s Scott Whitaker on The Medtech POV podcast for a conversation on several policy initiatives.
AdvaMed Accel® held the 2nd Quarter meeting of the Medtech Investment Working Group.
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs support scientific development and product innovation benefiting patients in need and the public at large.
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
The Q1 2022 meeting focuses on the diagnostics industry with presentations from Susan Van Meter, Executive Director of AdvaMedDx® and a discussion panel on deal-making in diagnostics.